Patents by Inventor Shinsuke Nakao

Shinsuke Nakao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10405315
    Abstract: A wireless communication terminal apparatus wherein even when a SC-FDMA signal is divided into a plurality of clusters and the plurality of clusters are then mapped to respective discontinuous frequency bands (when C-SC-FDMA is used), the improvement effect of system throughput can be maintained, while the user throughput can be improved. In the apparatus, a DFT unit (210) subjects a symbol sequence of time domain to a DFT process, thereby generating signals of frequency domain. A setting unit (211) divides the signals input from the DFT unit (210) into a plurality of clusters according to a cluster pattern that is in accordance with an MCS set, an encoding size, or the number of Ranks occurring during MIMO transmissions, which is indicated in those signals input, and then maps the plurality of clusters to the respective ones of a plurality of discontinuous frequency resources, thereby setting a constellation of the plurality of clusters in the frequency domain.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: September 3, 2019
    Assignee: Sun Patent Trust
    Inventors: Shinsuke Takaoka, Seigo Nakao, Daichi Imamura, Masayuki Hoshino
  • Publication number: 20190261403
    Abstract: A base station able to maintain backward compatibility with an LTE mobile station while minimizing the amount of increase in uplink scheduling information reception and demodulation/decoding processing in independent uplink/downlink cell data transmission. A wireless communication system includes a cell #1, a cell #2, and an LTE-A mobile station, and supports independent uplink/downlink cell data transmission. The base station of the cell #2 arranges a PDCCH+, which includes uplink scheduling information from the LTE-A mobile station to the base station of the cell #2, in a downlink data region in the downlink connection of the base station of the cell #1.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Inventors: Atsushi SUMASU, Shozo OKASAKA, Shinsuke TAKAOKA, Seigo NAKAO, Daichi IMAMURA
  • Publication number: 20190248904
    Abstract: [Problem] Provided is an anti-human BDCA-2 antibody for preventing or treating an autoimmune disease by binding to a human BDCA-2 to control the function of a plasmacytoid dendritic cell through human BDCA-2.
    Type: Application
    Filed: April 15, 2019
    Publication date: August 15, 2019
    Applicant: Astellas Pharma Inc.
    Inventors: Shinsuke NAKAO, Masayuki ITO, Yoshiyuki TENDA
  • Patent number: 10334622
    Abstract: A base station able to maintain backward compatibility with an LTE mobile station while minimizing the amount of increase in uplink scheduling information reception and demodulation/decoding processing in independent uplink/downlink cell data transmission. A wireless communication system includes a cell #1, a cell #2, and an LTE-A mobile station, and supports independent uplink/downlink cell data transmission. The base station of the cell #2 arranges a PDCCH+, which includes uplink scheduling information from the LTE-A mobile station to the base station of the cell #2, in a downlink data region in the downlink connection of the base station of the cell #1.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: June 25, 2019
    Assignee: SUN PATENT TRUST
    Inventors: Atsushi Sumasu, Shozo Okasaka, Shinsuke Takaoka, Seigo Nakao, Daichi Imamura
  • Patent number: 10294301
    Abstract: [Problem] Provided is an anti-human BDCA-2 antibody for preventing or treating an autoimmune disease by binding to a human BDCA-2 to control the function of a plasmacytoid dendritic cell through human BDCA-2.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: May 21, 2019
    Assignee: ASTELLAS PHARMA INC.
    Inventors: Shinsuke Nakao, Masayuki Ito, Yoshiyuki Tenda
  • Publication number: 20170340687
    Abstract: The present invention provides a genetically recombinant vaccinia virus effective in preventing or treating cancer. Specifically, the present invention provides a vaccinia virus comprising two polynucleotides, a polynucleotide encoding IL-7 and a polynucleotide encoding IL-12; a combination kit of two vaccinia viruses, a vaccinia virus comprising a polynucleotide encoding IL-7 and a vaccinia virus comprising a polynucleotide encoding IL-12; and use of the two vaccinia viruses in combination.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 30, 2017
    Applicants: Astellas Pharma Inc., National University Corporation Tottori University
    Inventors: Shinsuke Nakao, Tatsuya Kawase, Takafumi Nakamura
  • Publication number: 20160319025
    Abstract: [Problem] Provided is an anti-human BDCA-2 antibody for preventing or treating an autoimmune disease by binding to a human BDCA-2 to control the function of a plasmacytoid dendritic cell through human BDCA-2.
    Type: Application
    Filed: December 22, 2014
    Publication date: November 3, 2016
    Applicant: ASTELLAS PHARMA INC.
    Inventors: Shinsuke Nakao, Masayuki ITO, Yoshiyuki TENDA
  • Patent number: 6160324
    Abstract: A deadman switch mechanism and a teaching operation panel equipped with the deadman switch mechanism, in which possibility of losing a safety function is low even if failure happens in a contact or other elements of a circuit. When an operator grips at least one of grip levers (GL1; GL2) with normal force, the grip levers turn around axes (AX4; AX5), shoulder portions (SD1; SD2) abut on slave levers (SL1; SL2) and turns the slave levers connected by a link (LK) around an axis (AX3) in the direction denoted by an arrow B, simultaneously, so that switches (SW1; SW2) are turned into an ON-state, simultaneously. Then, two circuits including those switches, respectively, output ON-signals independently and these signals are subjected to AND process, to allow the robot to operate.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: December 12, 2000
    Assignee: Fanuc Ltd.
    Inventors: Akihiro Terada, Mitsuhiro Yasumura, Shinsuke Nakao